Study: No difference in complications, survival rate between robot-assisted and open bladder surgeries

A seven-year study comparing outcomes from robotic and open cystectomy procedures showed no statistically significant difference in complications or survival rate between the two methods. The randomized open versus robotic cystectomy study, known as the Razor trial, is touted as the first comprehensive study to compare outcomes between robotic and traditional open surgeries in any organ. Results from the trial were recently published in the journal The Lancet. “We have done more than 4 million surgeries with the robotic approach since the device came into existence, and on average we do close to a million robotic surgeries a year globally. There are close to 5,000 robotic systems installed all over the world – each one costs about $2 million – and yet until we did this study there was not a single Phase 3 multicenter randomized trial comparing this expensive new technology to the traditional open approach of doing surgeries,” study director and University of Miami Health System chief clinical officer Dr. Dipen Parekh said in a press release. The study recruited an initial 350 patients, with data from 302 patients eventually included in the analysis set. A total of  150 patients underwent robotic cystectomy procedures and 152 received open cystectomy treatments. Two-year progression free survival was reported at 72.3% for patients who underwent robotic procedures and 71.6% for those who underwent open cystectomy treatments. Adverse events were reported in 67...
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Robotics Surgical Source Type: news